Manual Wheelchair Segment has the Largest Share of Product in the Asia Pacific Wheelchair Market during 2021-2028
According to a new market research study on “Asia Pacific Wheelchair Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Product, Type, End-user, Application, Usage, and Distribution Channel” is expected to reach US$ 1,802.1 million by 2028 from US$ 1,095.8 million in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific wheelchair market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising population of geriatrics and rise in number of disorders requiring mobility assistance fuel the growth of the market are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the operational difficulties associated with wheelchairs and high cost of powered wheelchairs.
Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in wheelchair manufacturing industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient for private hospital chains. To relieve healthcare systems, many clinics have been postponing non-critical surgical procedures like orthopaedic and neuromuscular conditions. To avoid overburdening hospitals already struggling to deal with the rising pandemic pressure, doctors are delaying surgeries till the Covid-19 peak is past. Moreover, Medical device companies are starting to forecast large sales declines in their business segments because people are staying at home. Many big medical device companies such as Stryker, Invacare corporation and Medline Industries have predicated the decline in sales in china. Hospitals across China, Hong Kong and Taiwan have been deferring surgeries, to prevent the spread of the virus in the region. Thus, the impositions of lockdown and barriers in supply chain for wheelchairs are likely to negatively impact the growth of the market in 2020 and 2021. However, the countries such as India is conducting vaccination drive for the age group wise including the people within age group of 18 to 44, and 45 years and above. The country has also initiated testing of vaccine of the children which is expected to bring some positive prospects for the market.
The market for wheelchair market is segmented into product, type, application, End-user, usage, and distribution channel. Based on product, the wheelchair market is segmented into manual wheelchair, powered/electric wheelchair, and smart wheelchair. In 2020, the manual wheelchair segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of chronic conditions and demand for manual wheelchairs in emerging countries. Moreover, the prevalence of knee pain has witnessed massive growth of around 40% during past 4 decades. However, powered/ electric wheelchair segment is projected to register highest CAGR during the forecast period.
Medline Industries, Inc. OTTOBOCK, MEYRA GMBH, KARMAN HEALTHCARE, INC, Sunrise Medical, LEVO AG, and Permobil are among the leading companies in the Asia Pacific wheelchair market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in March 2020, Invacare Corporation has launched of the Invacare AVIVA FX Power Wheelchair. The AVIVA brand has a unique identity that conveys a promise of best-in-class design, technology, and performance.
According to a new market research study on “Asia Pacific Wheelchair Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Product, Type, End-user, Application, Usage, and Distribution Channel” is expected to reach US$ 1,802.1 million by 2028 from US$ 1,095.8 million in 2021. The market is estimated to grow at a CAGR of 7.4% from 2021 to 2028. The report provides trends prevailing in the Asia Pacific wheelchair market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the rising population of geriatrics and rise in number of disorders requiring mobility assistance fuel the growth of the market are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the operational difficulties associated with wheelchairs and high cost of powered wheelchairs.
Many measures have been implemented to contain the spread of COVID-19, that have resulted in significant operational disruption for many companies including in wheelchair manufacturing industry. Staff quarantine, supply-chain failures, and reductions in demand have generated serious complications for companies. Also, there has been a significant drop in in-patient and out-patient for private hospital chains. To relieve healthcare systems, many clinics have been postponing non-critical surgical procedures like orthopaedic and neuromuscular conditions. To avoid overburdening hospitals already struggling to deal with the rising pandemic pressure, doctors are delaying surgeries till the Covid-19 peak is past. Moreover, Medical device companies are starting to forecast large sales declines in their business segments because people are staying at home. Many big medical device companies such as Stryker, Invacare corporation and Medline Industries have predicated the decline in sales in china. Hospitals across China, Hong Kong and Taiwan have been deferring surgeries, to prevent the spread of the virus in the region. Thus, the impositions of lockdown and barriers in supply chain for wheelchairs are likely to negatively impact the growth of the market in 2020 and 2021. However, the countries such as India is conducting vaccination drive for the age group wise including the people within age group of 18 to 44, and 45 years and above. The country has also initiated testing of vaccine of the children which is expected to bring some positive prospects for the market.
The market for wheelchair market is segmented into product, type, application, End-user, usage, and distribution channel. Based on product, the wheelchair market is segmented into manual wheelchair, powered/electric wheelchair, and smart wheelchair. In 2020, the manual wheelchair segment accounted for the highest share of the market. Growth of this segment is attributed to the increasing prevalence of chronic conditions and demand for manual wheelchairs in emerging countries. Moreover, the prevalence of knee pain has witnessed massive growth of around 40% during past 4 decades. However, powered/ electric wheelchair segment is projected to register highest CAGR during the forecast period.
Medline Industries, Inc. OTTOBOCK, MEYRA GMBH, KARMAN HEALTHCARE, INC, Sunrise Medical, LEVO AG, and Permobil are among the leading companies in the Asia Pacific wheelchair market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in March 2020, Invacare Corporation has launched of the Invacare AVIVA FX Power Wheelchair. The AVIVA brand has a unique identity that conveys a promise of best-in-class design, technology, and performance.
The report segments the Asia Pacific Wheelchair market as follows:
By Product
- Manual Wheelchair
- Powered/Electric Wheelchair
- Standard Powered Wheelchairs
- Custom-Built Powered Wheelchairs
- Smart Wheelchair
By Type
- Centre Wheel Drive
- Front Wheel Drive
- Rear Wheel Drive
- Standing Electric Wheelchair
By Application
- Neurologically Impaired
- Handicap Patients
- Others
By End-user
- Rehabilitation Centres
- Hospitals and Clinics
- Homecare
- Ambulatory Surgical Centres
By Usage
- Adult
- Paediatric
By Distribution Channel
- Retail
- E-Commerce
By Country
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
Reasons to buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific wheelchair market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific wheelchair market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the wheelchair market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction
3. Research Methodology
4. Asia Pacific Wheelchair Market - Market Landscape
5. Asia Pacific Wheelchair Market - Key Market Dynamics
6. Wheelchair Market - Asia Pacific Analysis
7. Asia Pacific Wheelchair Market Analysis and Forecasts To 2028 - By Product
8. Asia Pacific Wheelchair Market Analysis and Forecasts To 2028 - By Type
9. Asia Pacific Wheelchair Market Analysis and Forecasts To 2028 - By End User
10. Asia Pacific Wheelchair Market Analysis and Forecasts to 2028 - By Application
11. Asia Pacific Wheelchair Market Analysis and Forecasts to 2028 - By Usage
12. Asia Pacific Wheelchair Market Analysis and Forecasts to 2028 - By Distribution Channel
13. Wheelchair Market Revenue and Forecasts to 2028 - Geographical Analysis
14. Impact Of COVID-19 Pandemic on Asia Pacific Wheelchair Market
15. Industry Landscape
16. COMPANY PROFILES
17. Appendix
List of Tables
List of Figures
Companies Mentioned
- Medline Industries, Inc.
- Ottobock
- Meyra Gmbh
- Karman Healthcare, Inc
- Sunrise Medical
- LEVO AG
- Permobil
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 147 |
Published | July 2021 |
Forecast Period | 2021 - 2028 |
Estimated Market Value ( USD | $ 1095.8 Million |
Forecasted Market Value ( USD | $ 1802.1 Million |
Compound Annual Growth Rate | 7.4% |
Regions Covered | Asia Pacific |
No. of Companies Mentioned | 7 |